Publicité
Publicité
RANI
Rani Therapeutics Holdings, Inc. Class A Common Stock
1.40
USDSponsorisé
0.00
0.00%
09 janv., 15:59 UTC -5
Fermé
Pré-marché
1.43
+0.03
+2.43%
RANI Rapports sur les bénéfices
Ratio de surprise positive
RANI a dépassé 15 des 18 dernières estimations.
83%
Prochain rapport
Date du prochain rapport
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Variation implicite de Q3 25 (Revenue/ EPS)
--
/--
Variation implicite de Q-- -1 (Revenue/ EPS)
--
/--
Rani Therapeutics Holdings, Inc. Class A Common Stock earnings per share and revenue
On 06 nov. 2025, RANI reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.12 USD, resulting in a 4.61% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -11.01% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analystes forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Rani Therapeutics Holdings, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Rani Therapeutics Holdings, Inc. Class A Common Stock reported EPS of -$0.12, beating estimates by 4.61%, and revenue of $0.00, 0% as expectations.
How did the market react to Rani Therapeutics Holdings, Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved down -11.01%, changed from $2.27 before the earnings release to $2.02 the day after.
When is Rani Therapeutics Holdings, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Rani Therapeutics Holdings, Inc. Class A Common Stock's next earnings report?
Based on --
analystes, Rani Therapeutics Holdings, Inc. Class A Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité